Cleared Traditional

MODIFICATION HYBRID CAPTURE II CT-ID DNA TEST, MODEL 03M91-01

K010892 · Digene Corp. · Microbiology
Sep 2001
Decision
182d
Days
Class 1
Risk

About This 510(k) Submission

K010892 is an FDA 510(k) clearance for the MODIFICATION HYBRID CAPTURE II CT-ID DNA TEST, MODEL 03M91-01, a Dna-reagents, Chlamydia (Class I — General Controls, product code LSK), submitted by Digene Corp. (Gaithersburg, US). The FDA issued a Cleared decision on September 24, 2001, 182 days after receiving the submission on March 26, 2001. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3120.

Submission Details

510(k) Number K010892 FDA.gov
FDA Decision Cleared SESE
Date Received March 26, 2001
Decision Date September 24, 2001
Days to Decision 182 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF

Device Classification

Product Code LSK — Dna-reagents, Chlamydia
Device Class Class I — General Controls
CFR Regulation 21 CFR 866.3120

Similar Devices — LSK Dna-reagents, Chlamydia

All 7
ABBOTT REALTIME CT/NG AND ABBOTT MULTI-COLLECT SPECIMEN COLLECTION KIT, MODELS 8L07-91, 9K12-03
K092704 · Abbott Molecular, Inc. · May 2010
MODIFICATION TO HYBRID CAPTURE II CT/GC TEST, MODEL 03M90-01
K010891 · Digene Corp. · Sep 2001
HYBRID CAPTURE II CT-ID TEST
K990023 · Digene Corp. · Oct 1999
PACE 2 CHLAMYDIA TRACHOMATIS PROBE CONFIRM ASSAY
K920302 · Gen-Probe, Inc. · Apr 1994
PACE 2 SYSTEM FOR CHLAMYDIA TRACHOMATIS
K920378 · Gen-Probe, Inc. · Apr 1992
GEN-PROBE(R) PACE(TM) SYSTEM CHLAMYDIA TRACHOMATIS
K874878 · Gen-Probe, Inc. · Dec 1987